Organ Preservation Market Size 2026-2030
The organ preservation market size is valued to increase by USD 134.64 million, at a CAGR of 7.2% from 2025 to 2030. Technological advancements in machine perfusion systems will drive the organ preservation market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 39% growth during the forecast period.
- By Type - Living organ donation segment was valued at USD 163.09 million in 2024
- By End-user - Hospitals and clinics segment accounted for the largest market revenue share in 2024
Market Size & Forecast
- Market Opportunities:
- Market Future Opportunities: USD 134.64 million
- CAGR from 2025 to 2030 : 7.2%
Market Summary
- The Organ Preservation Market demonstrates rapid structural evolution as healthcare systems shift from traditional cold storage toward dynamic mechanical perfusion solutions. Because hospitals increasingly prioritize higher graft success rates, administrators are overhauling procurement supply chains to integrate real-time functional evaluation hardware during organ transit.
- Facilities implementing these upgraded logistical frameworks have seen organ discard rates drop by 24% compared to legacy transport methods. Technological advancements in machine perfusion systems drive this momentum by enabling active cellular metabolism maintenance, effectively extending the allowable transit window for marginal donor organs.
- Conversely, the severe donor organ shortage remains a fundamental challenge, capping total addressable procedural volumes because hardware innovations cannot entirely offset the physical deficit of available donor tissue. These complex dynamics compel procurement networks to maximize the utility of every viable organ through precision transport protocols.
- Consequently, strategic investments in modular platform design and specialized transport media continue to reshape the operational benchmarks of modern transplantation infrastructure.
What will be the Size of the Organ Preservation Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Get Free Sample
How is the Organ Preservation Market Segmented?
The organ preservation industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD thousand" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.
- Type
- Living organ donation
- Deceased organ donation
- End-user
- Hospitals and clinics
- Organ banks
- Others
- Technique
- Static cold storage
- Hypothermic machine perfusion
- Normothermic machine perfusion
- Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- China
- India
- Japan
- South Korea
- Indonesia
- Thailand
- Rest of World (ROW)
- North America
By Type Insights
The living organ donation segment is estimated to witness significant growth during the forecast period.
Living organ donation procedures fundamentally alter transplant logistics coordination by utilizing preemptive physiological condition mimicking to maintain optimal metabolic viability.
Because procurement from living donors allows for immediate cellular integrity maintenance, surgical team operations can actively mitigate ischemia reperfusion injury more effectively than in emergency scenarios.
Facilities employing living donor workflows report that post operative complications decreased by 18% when utilizing specialized transport media alongside portable perfusion units.
This segment increasingly transitions away from traditional static cold storage toward advanced hypothermic machine perfusion, driven by strict regulatory clearance pathways demanding higher tissue injury reduction.
As organ procurement organizations refine their clinical validation protocols, the integration of these dynamic systems accelerates clinical translation acceleration, directly expanding the usable donor pool while ensuring superior graft survival optimization during complex transplantation procedures.
The Living organ donation segment was valued at USD 163.09 million in 2024 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 39% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Organ Preservation Market Demand is Rising in North America Get Free Sample
The regional adoption of advanced preservation modalities reveals distinct operational disparities between North America and Europe.
Facilities in North America demonstrate a 28% higher integration rate of hemodynamic monitoring modules compared to European centers, driven by aggressive capital investments from large academic medical centers.
Because North American procurement networks cover expansive geographic territories, their supply chains increasingly depend on ex vivo organ perfusion systems to ensure cellular integrity maintenance over longer transit durations.
Conversely, European markets achieve a 15% improvement in cost-efficiency by standardizing conventional media like the university of wisconsin solution and histidine tryptophan ketoglutarate across dense, cross-border procurement grids.
These differing regional approaches dictate how facilities deploy modular platform design strategies, resulting in a 20% faster clinical translation acceleration for new transport devices in the United States compared to the heavily regulated, fragmented European landscape.
Market Dynamics
Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
- Optimizing supply chain logistics remains a critical priority for medical institutions managing the delicate transfer of donor tissue. As transplant centers seek to enhance operational planning, the integration of advanced machine perfusion systems has revolutionized standard protocols, offering dynamic monitoring capabilities that significantly outpace legacy methods.
- Facilities transitioning to these mechanical platforms observe a 30% improvement in resource allocation efficiency compared to those relying entirely on static cold storage transit solutions. Because modern procurement networks demand rigorous compliance and real-time data tracking, ex vivo donor organ rehabilitation has emerged as a mandatory capability for handling high-risk tissues, directly reducing downstream clinical complications.
- Furthermore, continuous refinements in fluid chemistry, specifically through hypothermic preservation media optimization, enable transport teams to maintain cellular stability over vast geographic distances. By effectively extending donor graft viability window, organ procurement organizations can coordinate with surgical teams more reliably, minimizing emergency delays and lowering the logistical costs associated with discarded organs.
- This strategic pivot ensures that hospitals maximize the utility of their limited donor supply while adhering strictly to emerging regulatory standards for tissue safety. The continuous evolution of these specialized medical devices solidifies their role as essential assets within the broader healthcare infrastructure, streamlining the complex journey from organ retrieval to final implantation.
What are the key market drivers leading to the rise in the adoption of Organ Preservation Industry?
- Technological advancements in machine perfusion systems serve as the primary driver accelerating market expansion by extending the viability window for donor organs.
- The escalating necessity to utilize marginal donor organs acts as a primary catalyst accelerating the widespread adoption of normothermic machine perfusion technologies.
- Because traditional cold storage limits the safe transit window, clinical administrators are heavily investing in portable perfusion units equipped with digital telemetry monitoring to ensure superior tissue preservation.
- This strategic healthcare infrastructure integration reduces organ discard rates by 26% and improves logistical coordination efficiency by 15%. Strict regulatory clearance pathways increasingly mandate robust clinical validation protocols for complex transplantation procedures, compelling procurement organizations to abandon legacy coolers.
- As these dynamic systems actively sustain cellular metabolism during transit, they provide surgical teams with critical real-time data, ultimately driving higher procedural volumes and significantly lowering the operational costs associated with failed grafts.
What are the market trends shaping the Organ Preservation Industry?
- The expansion of ex vivo technology represents a significant upcoming trend shaping the market landscape. This advancement facilitates active donor organ rehabilitation and viability assessment prior to transplantation.
- The rapid transition toward dynamic ex vivo technologies fundamentally redefines organ viability assessment across the transplantation sector. Because specialized clinical facilities increasingly require physiological condition mimicking during transit, procurement organizations are overhauling standard operating procedures to incorporate systems with automated temperature control. This technological shift actively facilitates vascular bed circulation during long distance transit, directly mitigating cellular damage.
- Facilities adopting these advanced assessment protocols experience a 22% decrease in delayed graft function incidents and an 18% reduction in severe post operative complications. By enabling real time functional evaluation prior to surgery, these dynamic transport platforms drive significant donor pool expansion, allowing hospitals to safely utilize previously discarded organs.
- Consequently, this continuous innovation trend streamlines clinical workflows and elevates the overall operational efficiency of high-stakes transplant logistics.
What challenges does the Organ Preservation Industry face during its growth?
- The severe donor organ shortage and persistent supply-demand imbalance constitute a primary challenge restricting overall industry growth and procedural volume.
- The persistent structural deficit in available donor organs places immense strain on transplant logistics coordination, magnifying the critical risks associated with ischemia reperfusion injury. Because extended cold ischemia time severely degrades tissue quality, organ procurement organizations face escalating logistical costs when transporting grafts across fragmented regional networks.
- Failure to achieve adequate thermal excursion minimization using traditional temperature controlled enclosures often results in discarded organs, directly lowering institutional procedural efficiency by 14%. Furthermore, surgical team operations experience a 20% increase in emergency resource expenditure when managing compromised grafts that require extensive donor tissue rehabilitation upon arrival.
- These operational constraints compel medical facilities to continuously overhaul their supply chain protocols, as the fundamental shortage of physical organs strictly caps total procedural volume despite ongoing advancements in transport hardware.
Exclusive Technavio Analysis on Customer Landscape
The organ preservation market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the organ preservation market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Organ Preservation Industry
Competitive Landscape
Companies are implementing various strategies, such as strategic alliances, organ preservation market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
21st Century Medicine - The offering focuses on advanced perfusates and protocols designed for the viable, long-term cryopreservation of human organs and tissues to enhance transplant viability and cellular integrity.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- 21st Century Medicine
- Accord Healthcare Ltd.
- Artivion Inc.
- B.Braun SE
- BioLife Solutions Inc.
- Bridge to Life Ltd.
- Carnamedica
- CytoSorbents Corp.
- EBERS Medical Technology SL
- Global Transplant Solutions
- Institut Georges Lopez
- Organ Recovery Systems Inc.
- OrganOx Ltd.
- Paragonix Technologies Inc.
- Preservation Solution Inc.
- TransMedics Inc.
- XVIVO Perfusion AB
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Organ preservation market
- In the Life Sciences Tools and Services industry, the implementation of stringent ISO 13485 standards for medical device quality management has mandated stricter environmental controls during manufacturing, directly impacting Organ Preservation demand by accelerating the adoption of automated temperature control technologies.
- The restructuring of critical biochemical supply chains to prioritize localized production of pharmaceutical-grade polymers has stabilized raw material availability, increasing manufacturing throughput for oxygenated preservation solutions by 22%.
- The integration of AI-driven predictive analytics into laboratory information management systems has enhanced real-time workflow interoperability, improving testing efficiency by 15% and driving demand for Organ Preservation hardware equipped with continuous metabolic data monitoring.
- The expansion of specialized clinical trial centers focusing on regenerative medicine has intensified the requirement for high-viability cellular transport, expanding the operational use of Organ Preservation systems featuring digital telemetry monitoring to ensure compliance with clinical validation protocols.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Organ Preservation Market insights. See full methodology.
| Market Scope | |
|---|---|
| Page number | 278 |
| Base year | 2025 |
| Historic period | 2020-2024 |
| Forecast period | 2026-2030 |
| Growth momentum & CAGR | Accelerate at a CAGR of 7.2% |
| Market growth 2026-2030 | USD 134639.9 thousand |
| Market structure | Fragmented |
| YoY growth 2025-2026(%) | 6.7% |
| Key countries | US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, India, Japan, South Korea, Indonesia, Thailand, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Colombia, South Africa and Israel |
| Competitive landscape | Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- Modern transplantation logistics undergo a fundamental restructuring as healthcare administrators pivot toward data-driven transport modalities. The strategic integration of hardware capable of continuous metabolic data tracking allows surgical teams to proactively assess tissue viability, significantly mitigating risks associated with prolonged cold ischemia time.
- Because institutions must ensure stringent regulatory compliance, deploying advanced oxygenated preservation solutions has become a critical standard for optimizing supply chain reliability. Facilities that adopted these dynamic protocols report a 25% reduction in post-operative intensive care interventions, translating to substantial operational cost savings.
- This shift directly influences product procurement strategies, compelling hospitals to invest in versatile multi organ preservation platforms rather than single-use, organ-specific coolers. By prioritizing technologies that guarantee effective cellular metabolism arrest and robust anaerobic glycolysis mitigation, clinical directors can confidently accept marginal donor organs that previously failed transit criteria.
- Consequently, these boardroom-level budgeting decisions not only enhance overall procedural efficiency but also redefine the operational benchmarks for safe, high-volume organ procurement across global healthcare networks.
What are the Key Data Covered in this Organ Preservation Market Research and Growth Report?
-
What is the expected growth of the Organ Preservation Market between 2026 and 2030?
-
USD 134.64 million, at a CAGR of 7.2%
-
-
What segmentation does the market report cover?
-
The report is segmented by Type (Living organ donation, and Deceased organ donation), End-user (Hospitals and clinics, Organ banks, and Others), Technique (Static cold storage, Hypothermic machine perfusion, and Normothermic machine perfusion) and Geography (North America, Europe, Asia, Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Europe, Asia and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Technological advancements in machine perfusion systems, Severe donor organ shortage and supply-demand imbalance
-
-
Who are the major players in the Organ Preservation Market?
-
21st Century Medicine, Accord Healthcare Ltd., Artivion Inc., B.Braun SE, BioLife Solutions Inc., Bridge to Life Ltd., Carnamedica, CytoSorbents Corp., EBERS Medical Technology SL, Global Transplant Solutions, Institut Georges Lopez, Organ Recovery Systems Inc., OrganOx Ltd., Paragonix Technologies Inc., Preservation Solution Inc., TransMedics Inc. and XVIVO Perfusion AB
-
Market Research Insights
- The Organ Preservation Market requires robust healthcare infrastructure integration to facilitate seamless donor tissue management across vast procurement networks. By standardizing real time functional evaluation protocols, transplant centers have improved organ utilization rates by 18%, significantly lowering costs associated with delayed graft function.
- Furthermore, implementing advanced tracking during long distance transit has reduced thermal excursion incidents by 22%, ensuring better regulatory compliance. Because surgical teams rely on these optimized standard operating procedures, the overall efficiency of complex transplantation procedures has increased.
- This operational pivot ensures that specialized facilities can maximize clinical outcomes while strictly controlling the logistical expenditures tied to high-stakes organ procurement and delivery.
We can help! Our analysts can customize this organ preservation market research report to meet your requirements.
RIA - 
